Reach Pharmaceuticals Product Announcement

Reach Pharmaceuticals Pty Ltd has announced the approval and availability of Metabolics Potassium Citrate 10, potassium citrate 1.08g modified release tablets in a bottle of 100.

Reach has successfully registered this product for supply in Australia after another brand of potassium citrate modified tablets (Urocit-K) was discontinued in 2021.